Refractory Primary Mediastinal Large B-Cell Lymphoma: Clinical Trials

3 trials for Refractory Primary Mediastinal Large B-Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 suspended. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Recruiting 1, Suspended 1
Phase 22Recruiting 1, Suspended 1

Follow Refractory Primary Mediastinal Large B-Cell Lymphoma: new trials by email Literature Review of Refractory Primary Mediastinal Large B-Cell Lymphoma trials Research Report on Refractory Primary Mediastinal Large B-Cell Lymphoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma
Vevoctadekin, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1 / Phase 2SuspendedFred Hutchinson Cancer Center332025-12-272026-09-11
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Grade 3b Follicular Lymphoma
Phase 1 / Phase 2RecruitingYazeed Sawalha382025-04-022026-08-25
NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
Cyclophosphamide, Fludarabine, Lisocabtagene Maraleucel - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1CompletedFred Hutchinson Cancer Center272022-12-082026-09-21

Narrower conditions

Lymphoma, Large B-Cell, Diffuse (3)

Broader conditions

Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Lymphatic Diseases (3)  ·  Lymphoma (3)  ·  Lymphoma, B-Cell (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)

Interventions

Biopsy (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  Phantoms, Imaging (2)  ·  Spinal Puncture (2)  ·  X-Rays (2)  ·  Cyclophosphamide (1)  ·  Leukapheresis (1)  ·  NKTR-255 (1)  ·  Specimen Handling (1)  ·  fludarabine (1)  ·  ibrutinib (1)

Sponsors

Fred Hutchinson Cancer Center (2)  ·  Yazeed Sawalha (1)

Countries

United States (3)

Top investigators

Alexandre Hirayama (1)  ·  Alexandre V. Hirayama, MD (1)  ·  Yazeed Sawalha (1)